In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $19.60 in the last session, down -0.25% from day before closing price of $19.65. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 0.91 million shares were traded. SNDX stock price reached its highest trading level at $19.9251 during the session, while it also had its lowest trading level at $19.31.
Ratios:
We take a closer look at SNDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On January 31, 2024, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform and also lowered its target price recommendation from $36 to $23.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.Mizuho initiated its Buy rating on December 22, 2023, with a $45 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1672142720 and an Enterprise Value of 1236751616. For the stock, the TTM Price-to-Sale (P/S) ratio is 476.56 while its Price-to-Book (P/B) ratio in mrq is 3.84. Its current Enterprise Value per Revenue stands at 353.358 whereas that against EBITDA is -4.295.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is -8.33%, while the 200-Day Moving Average is calculated to be -6.79%.
Shares Statistics:
According to the various share statistics, SNDX traded on average about 1.02M shares per day over the past 3-months and 610440 shares per day over the past 10 days. A total of 84.83M shares are outstanding, with a floating share count of 79.44M. Insiders hold about 6.65% of the company’s shares, while institutions hold 97.07% stake in the company. Shares short for SNDX as of 1723680000 were 9434441 with a Short Ratio of 9.22, compared to 1721001600 on 8522704. Therefore, it implies a Short% of Shares Outstanding of 9434441 and a Short% of Float of 11.18.
